The Quality Digest is a recap of content aimed at advancing clinical care and excellence and keeping you informed about the latest regulations.
Clinical Advisory: Novavax COVID-19 Vaccine (Adjuvanted) Authorized and Available for Use
On 10/3/2023, the FDA amended the emergency use authorization of Novavax COVID-19 Vaccine, Adjuvanted to the 2023-2024 formula, revised to include spike protein from the SARS-CoV-2 Omicron variant lineage XBB.1.5. The original Novavax COVID-19 Vaccine is no longer authorized for use.
Did You Know? Medications with Shortened Expiration Dates
Once certain products are opened, they must be used within a specific timeframe to avoid reduced stability, sterility and potentially reduced efficacy. This list covers some common medications whose package inserts detail shortened expirations once in-use.
Pharmacogenomic risk assessments are a valuable tool that can help facilities prevent adverse drug events, reduce costs, and realize better outcomes. In this new e-guide, learn about the basics of pharmacogenomics, its benefits, and data applications, along with cost and coverage information.
PharMerica has partnered with SinguLab, a nationwide provider of precision medicine solutions, to offer pharmacogenomic risk assessments and testing to help facilities and providers identify, monitor, and manage potential issues associated with resident medications.
New Study in the Journal of the American Medical Directors Association Highlights the Continue Care Rx Program
The study, led by William Mills, MD, BrightSpring’s Senior Vice President of Medical Affairs, highlights the benefits of the Continue Care Rx Program (CCRx), a medication therapy and risk management program to keep patients healthier at home with fewer hospital visits and adverse health events.
Monthly drug regimen reviews (DRRs) by a pharmacist are required for each resident to help prevent adverse outcomes and minimize risk. As a high-risk drug class, a thorough review of opioid medications is an important part of the monthly DRR. Learn more about what’s required and the steps your facility can take for compliance.
CMS has provided guidance under F757 – Drug Regimen is Free from Unnecessary Drugs, directing surveyors to additionally consider facility compliance with F881 – Antibiotic Stewardship Program if the survey produces evidence of unnecessary antibiotic use.
Designed for long-term care professionals, our Spoonful of Sugar podcast with McKnight's looks at trends, issues, and the future of the skilled nursing, senior living, and behavioral health sectors. At about 20 minutes each, they'll bring you up to speed without taking up much of your day.
